Healthequity HQY 深 滬
等待開盤 12-13 09:30:00 美东时间
98.295
+0.905
+0.93%
華盛通- 最 高98.56
- 今 開97.90
- 成交量 20.30万股
- 最 低 97.49
- 昨 收 97.39
- 總市值 84.69亿
- 52周最高 116.65
- 市盈率 靜 90.29
- 換手率 0.00%
- 52周最低 74.07
- 委 比 61.54%
- 總股本 8615.63万
- 歷史最高 116.65
- 量 比 0.55
- 振 幅 1.10%
- 歷史最低 15.80
- 每 手 1
- 風險率 7.71%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
12-10 10:33
Young Americans Lead in HSA Adoption But Carry Heaviest Economic Burden, HealthEquity Research Finds
A recent survey by HealthEquity highlights a generational divide in healthcare financial preparedness. Younger Americans, particularly Gen Z and Millennials, lead in HSA adoption and benefits understanding, yet report higher economic anxiety and workplace financial stress. Despite their proactive approach, they are less prepared for unexpected healthcare costs compared to older generations. The survey emphasizes the need for better education and ...
12-09 14:00
美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元
12-05 08:35
BTIG Reiterates Buy on HealthEquity, Maintains $130 Price Target
BTIG analyst David Larsen reiterates HealthEquity (NASDAQ:HQY) with a Buy and maintains $130 price target.
12-04 18:06
HealthEquity Raises FY2026 Adj EPS Guidance from $3.74-$3.91 to $3.87-$3.95 vs $3.87 Est; Raises FY2026 Sales Guidance from $1.290B-$1.310B to $1.302B-$1.312B vs $1.310B Est
HealthEquity (NASDAQ:HQY) raises FY2026 Adj EPS guidance from $3.74-$3.91 to $3.87-$3.95 vs $3.87 analyst estimate. Raises FY2026 sales outlook from $1.290 billion-$1.310 billion to $1.302 billion-$1.312 billion vs
12-04 05:03
HealthEquity Q3 Adj. EPS $1.01 Beats $0.93 Estimate, Sales $322.164M Beat $321.027M Estimate
HealthEquity (NASDAQ:HQY) reported quarterly earnings of $1.01 per share which beat the analyst consensus estimate of $0.93 by 8.84 percent. This is a 29.49 percent increase over earnings of $0.78 per share from the same
12-04 05:01
Earnings Scheduled For December 3, 2025
Companies Reporting Before The Bell • Yuanbao (NASDAQ:YB) is likely to report e...
12-03 19:11
Insights into HealthEquity's Upcoming Earnings
HealthEquity (NASDAQ:HQY) is gearing up to announce its quarterly earnings on W...
12-02 22:01
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
11-14 10:43
BMO Capital Initiates Coverage On HealthEquity with Market Perform Rating, Announces Price Target of $100
BMO Capital analyst Sean Dodge initiates coverage on HealthEquity (NASDAQ:HQY) with a Market Perform rating and announces Price Target of $100.
11-13 19:00
